methylene blue has been researched along with Encephalopathy, Traumatic in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Genrikhs, EE; Isaev, NK; Kapkaeva, MR; Kondratenko, RV; Mukhaleva, EV; Skrebitsky, VG; Stelmashook, EV | 1 |
Alexandrova, OP; Fedorov, AV; Genrikhs, EE; Isaev, NK; Novikova, SV; Stelmashook, EV; Voronkov, DN | 1 |
Lin, AL; Sullivan, PG; Talley Watts, L; Vekaria, HJ | 1 |
Baek, S; Baik, JH; Choi, E; Jeong, K; Kim, B; Kim, D; Kim, S; Kim, YK; Lee, BH; Lee, JJ; Lee, KP; Lim, S; Park, J; Shin, S | 1 |
1 review(s) available for methylene blue and Encephalopathy, Traumatic
Article | Year |
---|---|
Targeting mitochondrial dysfunction in CNS injury using Methylene Blue; still a magic bullet?
Topics: Animals; Brain; Brain Injuries, Traumatic; Central Nervous System Diseases; Drug Delivery Systems; Energy Metabolism; Humans; Methylene Blue; Mitochondria | 2017 |
3 other study(ies) available for methylene blue and Encephalopathy, Traumatic
Article | Year |
---|---|
Neuroprotective Effects of Methylene Blue In Vivo and In Vitro.
Topics: Animals; Brain Injuries, Traumatic; Cells, Cultured; Male; Methylene Blue; Neurons; Neuroprotective Agents; Paraquat; Rats, Wistar | 2019 |
The single intravenous administration of methylene blue after traumatic brain injury diminishes neurological deficit, blood-brain barrier disruption and decrease in the expression of S100 protein in rats.
Topics: Administration, Intravenous; Animals; Blood-Brain Barrier; Brain Injuries, Traumatic; Cells, Cultured; Enzyme Inhibitors; Gene Expression; Hand Strength; Male; Methylene Blue; Nervous System Diseases; Neuroprotective Agents; Rats; Rats, Wistar; S100 Proteins | 2020 |
Nootropic nanocomplex with enhanced blood-brain barrier permeability for treatment of traumatic brain injury-associated neurodegeneration.
Topics: Animals; Anti-Inflammatory Agents; Blood-Brain Barrier; Brain Injuries, Traumatic; Cell Line; Drug Carriers; Humans; Male; Methylene Blue; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Nanostructures; Neurodegenerative Diseases; Neuroprotective Agents; Nootropic Agents; Permeability; Poloxamer | 2018 |